Categories: The Charlton Centre

#WiseWordsWednesday: Project ECHO

Project ECHO (Extension for Community Healthcare Outcomes) is a collaborative model of medical education that empowers all types of health care professionals to provide better care to more people in their own communities. Wait times to see specialists can be lengthy and those in remote communities may have challenges being able to travel long distances to these appointments. Project ECHO was first launched in New Mexico for better access to Hepatitis C treatments and recently came to Ontario, focusing on: Hepatitis C, pain, mental health. In January, ProjectECHO added rheumatology as a new speciality focus where family physicians, nurses, pharmacists, physiotherapists, occupational therapists, and chiropractors from over 20 sites across the province access a live video conference for a two-hour weekly session. A team of experts in rheumatology, called “the hub,” share their knowledge through a brief weekly lecture, followed by group discussion and problem solving of cases brought forward by the participating community members. It is a wonderful learning community.

Our pharmacist Carolyn Whiskin is the pharmacist expert on the Rheumatology “hub”. We encourage health professionals from across the province to join this wonderful government sponsored learning opportunity.

admin

Recent Posts

Bimzelx Now Approved for Hidradenitis Suppurativa (HS)

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition that can be very painful and…

4 days ago

Happy Holidays from Charlton Health

As the year comes to a close, we wish you a joyful holiday season filled…

3 weeks ago

Winrevair: A New Treatment Option for Pulmonary Arterial Hypertension (PAH)

Pulmonary arterial hypertension occurs when there is increased pressure in the small blood vessels that…

1 month ago

New Biologic Treatment for PMR (Polymyalgia Rheumatica)

Polymyalgia rheumatica (PMR) is an inflammatory condition that causes widespread joint and muscle pain along…

2 months ago

Expanded Protection: RSV Vaccine Now Approved for More Adults

Respiratory Syncytial Virus (RSV) is a common virus that can cause serious lung infections, particularly in…

2 months ago

Rinvoq: A New Oral Option for Giant Cell Arteritis

Health Canada has recently approved Rinvoq (upadacitinib) for adults living with Giant Cell Arteritis (GCA). Rinvoq…

3 months ago